Physician profile
Peter Boucas
NPI 1871054478
$4,595.91
in general payments reported to CMS, 2019-2025
13 companies · $2,458 in 2025
The $2,458 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,138 · 2025: $2,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,989 · Travel and Lodging: $1,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,989.11 |
| Travel and Lodging | $1,606.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $1,132.86 | 2024 | |
| Depuy Synthes Sales INC. | $914.87 | 2024-2025 | Teligen, Motoband, Na |
| Medtronic, INC. | $685.26 | 2024-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Unid_pass, Cd Horizon Spinal System |
| Medical Device Business Services, INC. | $547.92 | 2025 | Velys |
| Globus Medical, INC. | $373.54 | 2024 | Allocate, Coalition |
| Cerapedics INC. | $256.28 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Davol INC. | $172.60 | 2025 | Avitene Ultrafoam |
| Sanara Medtech INC. | $148.17 | 2025 | Celleraterx |
| Stryker Corporation | $145.41 | 2025 | Gamma |
| Augmedics INC. | $82.37 | 2025 | Xvision |
| Oak Med, INC. | $60.07 | 2025 | |
| Novapproach Spine, LLC | $59.76 | 2024 | Onelif |
| Vertex Pharmaceuticals Incorporated | $16.80 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Boucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.